Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102994470A details a novel Aus EH-B enzyme for high-purity chiral epichlorohydrin. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN104263802B enables high-purity S-1-tetrahydronaphthalene amines via dynamic kinetic resolution, ensuring supply chain reliability.
Patent CN101823993A reveals a low-cost, high-yield hydrogenation route for L-octahydroindoline-2-formic acid, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN101823993A reveals a low-cost, high-yield hydrogenation route for L-octahydroindoline-2-carboxylic acid, offering significant supply chain advantages for pharma intermediates.
Patent CN104151229B details a high-yield resolution process for Levamlodipine intermediates using DMSO-d6, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN106432195B reveals a streamlined route for (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, enhancing purity and reducing costs.
Novel enzymatic resolution method for ambrisentan reduces solvent use and improves yield. Ideal for reliable API intermediate supplier partnerships.
Patent CN104152527A details DKR method for R-2-naphthylethylamine. High purity, cost-effective Raney Nickel catalyst. Reliable supply chain for pharmaceutical intermediates.
Patent CN111363736A reveals a novel enzymatic route for dexketoprofen using Klebsiella amidase, offering superior ee values and greener manufacturing for pharmaceutical intermediates.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN103342676A reveals high-purity D-tryptophan synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN109180496B details a novel lipase-catalyzed resolution and Mitsunobu reaction for Cinacalcet. Achieve high purity without hazardous reducing agents.
Patent CN106748825A details a novel synthesis route for Dapoxetine. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101573330A reveals a novel stereo-selective route for trans-[18F]-FACBC precursors, offering significant cost reduction in PET tracer manufacturing and supply chain reliability.
Patent CN101974604B details a novel ionic liquid biocatalysis route for paroxetine intermediates, offering high optical purity and reduced environmental impact for reliable supply chains.
Patent CN1053431A reveals an advanced method for Fosinopril synthesis, offering improved stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Novel patent CN106916074A offers high-purity Tomoxetine Hydrochloride synthesis with recyclable solvents and reduced environmental impact for reliable supply.
Patent CN113429328A details a low-cost tartaric acid resolution method for chiral fluorinated pyrrolidines, enabling scalable API intermediate production.
Patent CN117658830B enables high-optical-purity trans-2-aminocyclopentanol synthesis. Safe resolution process offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101974604A reveals a green enzymatic route for paroxetine intermediates using ionic liquids, offering high purity and reduced environmental impact for API manufacturing.